During the past decade, Sociedade Beneficente de Senhoras Hospital Sirio Libanes conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 11 clinical trials were completed, i.e. on average, 34.4% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 8 clinical trials were completed. i.e. 32% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sociedade Beneficente de Senhoras Hospital Sirio Libanes" #1 sponsor was "Janssen Research & Development, LLC" with 8 trials, followed by "Amgen" with 4 trials sponsored, "Celgene" with 4 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored and "Mirum Pharmaceuticals, Inc." with 3 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sociedade Beneficente de Senhoras Hospital Sirio Libanes" #1 collaborator was "Brazilian Research In Intensive Care Network" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Hospital do Coracao" with 2 trials as a collaborator, "Ache Laboratorios Farmaceuticos S.A." with 1 trials as a collaborator and "EMS" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Sociedade Beneficente de Senhoras Hospital Sirio Libanes" are "Metastatic Breast Cancer" (3 trials), "Breast Cancer" (2 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Non-Small Cell Lung Cancer" (2 trials) and "Pneumonia, Viral" (2 trials). Many other conditions were trialed in "Sociedade Beneficente de Senhoras Hospital Sirio Libanes" in a lesser frequency.

Most popular intervention types in "Sociedade Beneficente de Senhoras Hospital Sirio Libanes" are "Drug" (32 trials), "Other" (7 trials), "Biological" (3 trials), "Radiation" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Dexamethasone" (3 trials), "Erdafitinib" (3 trials), "Maralixibat" (3 trials) and "Abemaciclib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Sociedade Beneficente de Senhoras Hospital Sirio Libanes" are 33 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Sociedade Beneficente de Senhoras Hospital Sirio Libanes". undefined are not yet recruiting, 15 are recruiting, 9 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 9 completed trials in Sociedade Beneficente de Senhoras Hospital Sirio Libanes, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Sociedade Beneficente de Senhoras Hospital Sirio Libanes, 3 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".